Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2
about
sameAs
Proteins interacting with cloning scars: a source of false positive protein-protein interactionsA novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stabilityThe inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosisThe A20-binding protein ABIN-2 exerts unexpected function in mediating transcriptional coactivationA20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteinsInflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activationLIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activationA20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activityModular decomposition of protein-protein interaction networksThe promyelocytic leukemia protein represses A20-mediated transcriptionRegulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinaseABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responsesStructure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes.ZNF216 Is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation.Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M.Shielding the double-edged sword: negative regulation of the innate immune system.Functions of NF-kappaB1 and NF-kappaB2 in immune cell biologyABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actionsUSP35 activated by miR let-7a inhibits cell proliferation and NF-κB activation through stabilization of ABIN-2Charting protein complexes, signaling pathways, and networks in the immune system.MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathwayModulation of neoplastic gene regulatory pathways by the RNA-binding factor AUF1HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA.The negative regulation of Toll-like receptor and associated pathways.Tumor Necrosis Factor-alpha Induced Protein 3 Interacting Protein 1 Gene Polymorphisms and Pustular Psoriasis in Chinese Han Population.Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.A20: central gatekeeper in inflammation and immunity.Sodium methyldithiocarbamate exerts broad inhibition of cellular signaling and expression of effector molecules of inflammation.Regulation of NF-κB by deubiquitinases.TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.NFκB-inducing kinase inhibits NFκB activity specifically in neurons of the CNS.MiR-663a/MiR-423-5p are involved in the pathogenesis of lupus nephritis via modulating the activation of NF-κB by targeting TNIP2.Bindarit reduces the incidence of acute aortic dissection complicated lung injury via modulating NF-κB pathway.NF kappa B controls the balance between Fas and tumor necrosis factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20.N-Myc-Interacting Protein Negatively Regulates TNF-α-Induced NF-κB Transcriptional Activity by Sequestering NF-κB/p65 in the Cytoplasm.Nucling interacts with nuclear factor-kappaB, regulating its cellular distribution.
P2860
Q24289298-8C7A684E-FA2C-4FEE-9D3E-B4C3B6CF55EEQ24292059-01B955D9-33A1-4DF3-AB53-241A3A68CD37Q24294653-B9CBCFF6-E081-49EB-846B-6CBF355790BAQ24300971-B399ED7A-D0B0-4B21-961E-DCF63A6C0EF8Q24302016-B1734CB1-551D-419B-8A11-F42827D6C0CEQ24304048-4CEB60B1-3639-4B35-B270-31AB4C2EB0EAQ24307510-8FCB9AC6-0424-4F8B-AA50-1A6126C32640Q24309469-A0AB0B62-7EED-4A9E-94D3-72FE86179DA4Q24312754-6ED9D7F9-195D-4B72-9FF3-AA0766FB3FCDQ24316467-93E1A004-4976-43DA-A12D-6181721E15A7Q24797641-381621A5-BF2C-433E-9A9F-C6016112666CQ28206387-2C0A6576-AEDB-4C88-BAD9-36D9FA9C21C3Q28392677-2E2521C3-D34A-484D-9AFF-C1838F7AA683Q28585458-3778007D-5E90-45C2-B47D-5988ADA2AEDCQ28588018-C2AB3BFB-DE6A-42D2-921C-AB5BDDB3A362Q33209988-73664800-9FE7-4206-8DE1-1232E2C1DCB9Q33405651-2025B3D9-0CCD-40C9-A9E3-0CD7CB81D226Q34293933-1AF4A416-1BBF-4C05-A1CC-E60092550F12Q34997280-F7369A53-6564-4981-A891-24069341C5AFQ35575529-E482A82D-A4FD-4343-9C21-C53954E00E25Q35815962-D8B396D1-4D29-459E-A904-D577F7CD3811Q35948145-F709BDCC-58AB-4CE4-855F-5D92B79F1626Q36413933-FF0EA2B9-3373-46E0-A367-21A373038DA7Q36453373-E0F8ADED-631F-455F-AB8F-B44046000C57Q36633464-13CC1DB3-7CDA-4C17-A4E2-6E9BF9749A7AQ36661312-55D47DE8-0D8D-4631-815C-B5251317EC02Q36744542-39895F2F-E155-4293-81B1-070BD75445C4Q36875508-938D2D9E-84A0-48F1-BB2D-2CB3334B5190Q37061011-BF171148-5BCF-483D-AD25-5799AEA38DDBQ37296391-B54A4DBC-ABF6-4BE1-9E32-5E60BF4828B9Q37325315-5E5B05C7-7A02-407E-9BE5-4EBB71F79F47Q37380773-CF53F4E2-D9FE-4487-AACA-30A78212814BQ37995682-405B1F1F-7F9A-47FD-9009-0E64C2E7E916Q38440904-A524FE65-79BE-4F9B-A4A8-B24EFE067F4FQ40096005-4AEEE3BD-AB6E-4B9C-A1D2-7EAB0E0626CBQ41549409-0B2132AB-9880-48ED-9427-1BA3EFFDDCBAQ41671938-5D92DD0A-4B28-4424-95AF-7130EA4F9246Q43822883-8822D845-025B-401B-9847-0661DE393647Q46322446-D64A0CAF-5D45-481C-B1C2-9B78845FC47BQ53418301-9A1F3991-5904-46C4-B6C1-9264D6190031
P2860
Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@ast
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@en
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@nl
type
label
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@ast
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@en
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@nl
prefLabel
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@ast
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@en
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@nl
P2093
P2860
P356
P1476
Identification of a novel A20- ...... ppa B activation termed ABIN-2
@en
P2093
D De Valck
K Heyninck
S Van Huffel
P2860
P304
30216-30223
P356
10.1074/JBC.M100048200
P407
P50
P577
2001-06-04T00:00:00Z